APA (7th ed.) Citation

Kim, J., Noh, J., Park, J., Chung, H., Kim, K., Park, S. B., . . . Park, J. (2022). Dabigatran Acylglucuronide, the Major Metabolite of Dabigatran, Shows a Weaker Anticoagulant Effect than Dabigatran. MDPI AG.

Chicago Style (17th ed.) Citation

Kim, Jong-Min, Jihyeon Noh, Jin-Woo Park, Hyewon Chung, Kyoung-Ah Kim, Seung Bin Park, Jun-Seok Lee, and Ji-Young Park. Dabigatran Acylglucuronide, the Major Metabolite of Dabigatran, Shows a Weaker Anticoagulant Effect than Dabigatran. MDPI AG, 2022.

MLA (9th ed.) Citation

Kim, Jong-Min, et al. Dabigatran Acylglucuronide, the Major Metabolite of Dabigatran, Shows a Weaker Anticoagulant Effect than Dabigatran. MDPI AG, 2022.